226 related articles for article (PubMed ID: 29498642)
1. Estrogen Receptor Signaling in Radiotherapy: From Molecular Mechanisms to Clinical Studies.
Rong C; Meinert ÉFRC; Hess J
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29498642
[TBL] [Abstract][Full Text] [Related]
2. Nuclear and extranuclear-initiated estrogen receptor signaling crosstalk and endocrine resistance in breast cancer.
Kulkoyluoglu E; Madak-Erdogan Z
Steroids; 2016 Oct; 114():41-47. PubMed ID: 27394959
[TBL] [Abstract][Full Text] [Related]
3. [Breast cancer: radiotherapy and estrogen signaling].
Bourgier C; Lemanski C; Romieu G; Ozsahin M; Azria D
Bull Cancer; 2014; 101(7-8):714-7. PubMed ID: 25091654
[TBL] [Abstract][Full Text] [Related]
4. Sex hormone receptors in breast cancer.
D'Abreo N; Hindenburg AA
Vitam Horm; 2013; 93():99-133. PubMed ID: 23810004
[TBL] [Abstract][Full Text] [Related]
5. Structural and functional characterization of aromatase, estrogen receptor, and their genes in endocrine-responsive and -resistant breast cancer cells.
Chan HJ; Petrossian K; Chen S
J Steroid Biochem Mol Biol; 2016 Jul; 161():73-83. PubMed ID: 26277097
[TBL] [Abstract][Full Text] [Related]
6. Function of G-Protein-Coupled Estrogen Receptor-1 in Reproductive System Tumors.
Qian H; Xuan J; Liu Y; Shi G
J Immunol Res; 2016; 2016():7128702. PubMed ID: 27314054
[TBL] [Abstract][Full Text] [Related]
7. Endocrine therapy resistance: current status, possible mechanisms and overcoming strategies.
Chang J; Fan W
Anticancer Agents Med Chem; 2013 Mar; 13(3):464-75. PubMed ID: 22931419
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptors: selective ligands, partners, and distinctive pharmacology.
Katzenellenbogen BS; Montano MM; Ediger TR; Sun J; Ekena K; Lazennec G; Martini PG; McInerney EM; Delage-Mourroux R; Weis K; Katzenellenbogen JA
Recent Prog Horm Res; 2000; 55():163-93; discussion 194-5. PubMed ID: 11036937
[TBL] [Abstract][Full Text] [Related]
9. EPRS is a critical regulator of cell proliferation and estrogen signaling in ER+ breast cancer.
Katsyv I; Wang M; Song WM; Zhou X; Zhao Y; Park S; Zhu J; Zhang B; Irie HY
Oncotarget; 2016 Oct; 7(43):69592-69605. PubMed ID: 27612429
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer.
Simigdala N; Gao Q; Pancholi S; Roberg-Larsen H; Zvelebil M; Ribas R; Folkerd E; Thompson A; Bhamra A; Dowsett M; Martin LA
Breast Cancer Res; 2016 Jun; 18(1):58. PubMed ID: 27246191
[TBL] [Abstract][Full Text] [Related]
11. WNT4 mediates estrogen receptor signaling and endocrine resistance in invasive lobular carcinoma cell lines.
Sikora MJ; Jacobsen BM; Levine K; Chen J; Davidson NE; Lee AV; Alexander CM; Oesterreich S
Breast Cancer Res; 2016 Sep; 18(1):92. PubMed ID: 27650553
[TBL] [Abstract][Full Text] [Related]
12. Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy.
Cui X; Schiff R; Arpino G; Osborne CK; Lee AV
J Clin Oncol; 2005 Oct; 23(30):7721-35. PubMed ID: 16234531
[TBL] [Abstract][Full Text] [Related]
13. A 2009 update on the treatment of patients with hormone receptor-positive breast cancer.
Cleator SJ; Ahamed E; Coombes RC; Palmieri C
Clin Breast Cancer; 2009 Jun; 9 Suppl 1():S6-S17. PubMed ID: 19561006
[TBL] [Abstract][Full Text] [Related]
14. STAT3-survivin signaling mediates a poor response to radiotherapy in HER2-positive breast cancers.
Kim JS; Kim HA; Seong MK; Seol H; Oh JS; Kim EK; Chang JW; Hwang SG; Noh WC
Oncotarget; 2016 Feb; 7(6):7055-65. PubMed ID: 26755645
[TBL] [Abstract][Full Text] [Related]
15. Towards prediction and modulation of treatment response.
Bartelink H; Begg A; Martin JC; van Dijk M; van 't Veer L; van der Vaart P; Verheij M
Radiother Oncol; 1999 Jan; 50(1):1-11. PubMed ID: 10225551
[TBL] [Abstract][Full Text] [Related]
16. NFκB affects estrogen receptor expression and activity in breast cancer through multiple mechanisms.
Frasor J; El-Shennawy L; Stender JD; Kastrati I
Mol Cell Endocrinol; 2015 Dec; 418 Pt 3(0 3):235-9. PubMed ID: 25450861
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitor induced modulation of anti-estrogen therapy.
Thomas S; Munster PN
Cancer Lett; 2009 Aug; 280(2):184-91. PubMed ID: 19185986
[TBL] [Abstract][Full Text] [Related]
18. Estrogen signaling and unfolded protein response in breast cancer.
Rajapaksa G; Thomas C; Gustafsson JÅ
J Steroid Biochem Mol Biol; 2016 Oct; 163():45-50. PubMed ID: 27045680
[TBL] [Abstract][Full Text] [Related]
19. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells.
Pietras RJ; Márquez DC; Chen HW; Tsai E; Weinberg O; Fishbein M
Steroids; 2005; 70(5-7):372-81. PubMed ID: 15862820
[TBL] [Abstract][Full Text] [Related]
20. Estrogen-mediated mechanisms to control the growth and apoptosis of breast cancer cells: a translational research success story.
McDaniel RE; Maximov PY; Jordan VC
Vitam Horm; 2013; 93():1-49. PubMed ID: 23810002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
